HEMACORD® the First FDA-Licensed Stem Cell Product
HEMACORD® (HPC, Cord Blood) consists of hematopoietic progenitor cells, monocytes, lymphocytes, and granulocytes from human cord blood. Blood recovered from umbilical cord and placenta is volume reduced and partially depleted of red blood cells and plasma.
For complete information on Indications and Usage, Contraindications, Important Safety Information, Warnings and Precautions, and Adverse Reactions, please visit our full product website.
Investigational New Drug (IND) Cord Blood Units
In 1996, we became the first cord blood bank to receive an IND exemption from the FDA. Our extensive inventory of clinical-grade, IND units is available for distribution directly to over 60 leading transplant centers worldwide, as well as through major international registries.
How to Request a Cord Blood Unit
Most major transplant centers submit “Search Requests” directly to our program using our proprietary online search platform called Web Search. From there, our staff of experts coordinates the identification, testing and transport of cord blood units to national and international transplant centers.
In addition to our online platform, transplant centers have two other indirect means for searching and procuring from our inventory:
- The National Marrow Donor Program (NMDP) operates the Be the Match™ Registry which serves as the single point of access for the National Cord Blood Inventory (as described under the federally-sponsored C.W. Bill Young Cell Transplantation Program). Out entire clinical inventory, including those designated for the National Cord Blood Inventory, is available on the Be the Match™ search database.
- The World Marrow Donor Association (WMDA) maintains an international registry of bone marrow donors and cord blood units, and its search engine finds matches and provides requesting transplant centers the IDs and banks (or registries) of the matched bone marrow or cord blood donors.